Dalemans SRL
1.0 FTEThe score of Dalemans shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets +90 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dalemans's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 13 Oct 2025
- Year ended 31 Dec 2023filed on 26 Sep 2024
- Year ended 31 Dec 2022filed on 22 Dec 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Dalemans's financial analysis
- Solvency41.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dalemans
Dalemans's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0419.971.002
- VAT number
- BE0419971002
- Peppol
- Registered · 0208:0419971002 · as of 03 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Dec 1979
- Registered office
- 9255 Buggenhout
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dalemans (SRL) has been based in Buggenhout since 1979, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 22,317 € and equity of 500,348 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 41.8%, below the median of its sector (44.2%).
Companies similar to Dalemans
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Baetens Retail sale of pharmaceutical products Evergem · balance sheet €1.20m
- Diximo Retail sale of pharmaceutical products Ferrières · balance sheet €1.20m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
- Pharmacie Elodie TRINTELER Retail sale of pharmaceutical products Tournai · balance sheet €1.20m
- Jolypharma Retail sale of pharmaceutical products Riemst · balance sheet €1.20m
- Hingiphar Retail sale of pharmaceutical products Kampenhout · balance sheet €1.20m
- Hulspharma Retail sale of pharmaceutical products Hulshout · balance sheet €1.20m
- Pharmaphie SDW Retail sale of pharmaceutical products Ghent · balance sheet €1.19m
Frequently asked questions about Dalemans
What is the revenue of Dalemans?
Dalemans files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dalemans?
In Belgium, the VAT number is the company number prefixed with BE: BE0419971002 for Dalemans, if the company is VAT-registered. Its company number (CBE) is 0419.971.002.
Where is the registered office of Dalemans?
According to the CBE register, the registered office of Dalemans is in 9255 Buggenhout.
What is the equity of Dalemans?
At the close of the 2025 financial year, the equity of Dalemans amounts to 500,348 €, a solvency of 41.8% of total assets.
How many people work at Dalemans?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dalemans?
The register lists 2 active mandates at Dalemans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dalemans
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →